Results Among 1870 patients receiving maintenance dialysis, 1569 had no prior COVID-19.
Patients without prior COVID-19 had declining titers over time. Among 443 recipients of …

As of October 2021, 3 SARS-CoV-2 vaccines are available in the United States, and all
appear highly effective in the general population. Studies suggest high seroresponse to …

Rationale & Objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections are likely underdiagnosed, but the degree of underdiagnosis among patients receiving …

Beginning August 13, 2021, third doses of SARS-CoV-2 mRNA vaccine were recommended
for patients with immunocompromise, 1 possibly but not definitively including patients …

Increasing hemodialysis frequency from three to six times per week improves left-ventricular
mass and health-related quality of life; however, effects on survival remain uncertain. To …

Rationale & Objectives Dialysis patients frequently experience medication-related problems.
We studied the association of a multidisciplinary medication therapy management (MTM) …

Rationale & Objective High-dose influenza vaccine provides better protection against
influenza infection in older adults than standard-dose vaccine. We compared vaccine …

Results Between September 1 and December 31, 2015, standard dose trivalent, standard
dose quadrivalent, and high-dose trivalent influenza vaccines were administered to 3057 (31%…

Background SARS-CoV-2 vaccine effectiveness during the Delta period and immunogenicity
threshold associated with protection against COVID-19 related hospitalization or death in …

Background: The SARS-COV-2 pandemic (COVID) impacted ESRD patients on dialysis,
categorized by the CDC as immunocompromised. We describe the characteristics and …